Written Question · S3W-31367 · Session 3
What process or procedures need to be followed to allow the drug, low dose naltrexone (LDN), to be offered more widely to people with multi…
The question
To ask the Scottish Executive what process or procedures need to be followed to allow the drug, low dose naltrexone (LDN), to be offered more widely to people with multiple sclerosis.
The answer
I refer the member to the answer to question S3W-31365 on 24 February 2010. All answers to written parliamentary questions are available on the Parliament''s website, the search facility for which can be found at http://www.scottish.parliament.uk/Apps2/Business/PQA/Default.aspx.
In the Official Report
No contribution in the Official Report cites S3W-31367 by reference.